scispace - formally typeset
D

David Spiegel

Researcher at Stanford University

Publications -  838
Citations -  50967

David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.

Papers
More filters
Journal ArticleDOI

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

TL;DR: The effect of psychosocial intervention on time of survival of 86 patients with metastatic breast cancer was studied prospectively and survival plots indicated that divergence in survival began at 20 months after entry, or 8 months after intervention ended.
Journal Article

An estimation of the global volume of surgery : a modelling strategy based on available data. Commentary

TL;DR: In this paper, the authors estimated the number of major operations undertaken worldwide, described their distribution, and assessed the importance of surgical care in global public health policy, based on demographic, health, and economic data for 192 member states of the World Health Organization.
Journal ArticleDOI

Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival

TL;DR: Patients with metastatic breast cancer whose diurnal cortisol rhythms were flattened or abnormal had earlier mortality, and suppression of NK cell count and NK function may be a mediator or a marker of more rapid disease progression.
Journal ArticleDOI

Mood disorders in the medically ill: scientific review and recommendations.

TL;DR: A growing body of evidence suggests that biological mechanisms underlie a bidirectional link between mood disorders and many medical illnesses and there is evidence to suggest that mood disorders affect the course of medical illnesses.
Journal ArticleDOI

Emotion Modulation in PTSD: Clinical and Neurobiological Evidence for a Dissociative Subtype

TL;DR: The neural manifestations of the dissociative subtype in PTSD are compared to those underlying the reexperiencing/hyperaroused subtype and have important implications for treatment of PTSD, including the need to assess patients with PTSD for Dissociative symptoms and to incorporate the treatment of dissociatives symptoms into stage-oriented trauma treatment.